arginyl-glycyl-aspartyl-serine and Candida Infection

arginyl-glycyl-aspartyl-serine has been researched along with Candida Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Garner, RE; Hudson, JA; Sawyer, RT	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Candida Infection

Article	Year
Arg-Gly-Asp (RGD) peptides alter hepatic killing of Candida albicans in the isolated perfused mouse liver model. Infection and immunity, 1992, Volume: 60, Issue:1 Topics: Amino Acid Sequence; Animals; Bacterial Adhesion; Candidiasis; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Fibronectins; Liver; Mice; Molecular Sequence Data; Oligopeptides; Organ Culture Techniques; Peptides; Perfusion; Platelet Aggregation Inhibitors; Receptors, Immunologic	1992

Article

Year

Arg-Gly-Asp (RGD) peptides alter hepatic killing of Candida albicans in the isolated perfused mouse liver model.

Infection and immunity, 1992, Volume: 60, Issue:1

Topics: Amino Acid Sequence; Animals; Bacterial Adhesion; Candidiasis; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Fibronectins; Liver; Mice; Molecular Sequence Data; Oligopeptides; Organ Culture Techniques; Peptides; Perfusion; Platelet Aggregation Inhibitors; Receptors, Immunologic

1992